Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
-
Applied Optoelectronics Announces Completion of Previously Announced At the Market Offering
-
Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial
-
10 Federal Formalizes Executive Leadership Team in Preparation for Company Growth, Naming Geoff Hayth President, Beau Agnello Chief Operating Officer and Brian Oakley Chief Technology Officer
-
Wellness Index Report: The Rise of 360-Degree Wellness
-
Insmed Announces CFO Transition
-
TriGemX Bio Strengthens Board of Directors with Appointment of Doug Pagán
-
Integral Ad Science to Provide Brand Safety and Suitability Measurement in ChatGPT Ads
-
Stoke Therapeutics Announces Completion of Successful Meeting with the FDA to Align on Planned U.S. NDA for Zorevunersen, an Investigational Medicine for the Treatment of Dravet Syndrome
-
Intruder Positioned as a Major Player in 2026 IDC MarketScape for Worldwide Dynamic Application Security Testing
-
Cut Cost with ezPaycheck for Mid-Year Payroll and Year-End Tax Form Processing
-
AerCap Leased, Purchased and Sold 204 Assets in the Third Quarter 2026
-
BrilliA Expands into Southeast Asian Specialty Retail with Acquisition of Majority Interest in Malaysian Lingerie Brand Neubodi
-
Social Video Ads Are Standing Out, But Losing the Brand, New Research From Zappi Finds
-
National Newspaper Week Asks Canadians Who Is Really Behind the News
-
Americold Realty Trust, Inc. Sets Date for Third Quarter 2026 Earnings Release and Conference Call
-
Traditional Medicinals Begins Production at New Virginia Manufacturing Facility
-
Stratasys Announces 2026 Annual General Meeting of Shareholders
-
Latus Bio Announces New Data Presentation at American Society of Nephrology (ASN) Kidney Week 2026
-
InTest Expects Record Orders for Q3 2026 and Revenue at High End of Guidance Range for Q3 and Full Year 2026
-
Magnachip Launches 15 New Gen6 E6 Super-Junction MOSFETs for TVs, Notebook Adapters and PC Power Supplies
-
AstraZeneca Completes $2 Billion Equity Investment in Summit Therapeutics
-
Slang AI Introduces the Superhost: The Most Natural Restaurant Caller Experience in the World
-
Keyfactor Appoints Former CyberArk CEO Matt Cohen to Board of Directors and Strategic Advisor
-
C.H. Robinson to Acquire RXO, Redefining the Future of Third-Party Logistics While Unlocking Significant Shareholder Value
-
D-Wave Partners with University of Arkansas to Establish Quantum Supply Chain Initiative at the Sam M. Walton College of Business
-
New 2026 Cell and Gene Therapy Report Charts the Path from Scientific Progress to Patient Access
-
Consensus Cloud Solutions to Host Q3 Investor Call on November 5, 2026
-
Agility Robotics CEO Peggy Johnson Selected to Join Project Meridian
-
PBT Land and Minerals Announces Record Date and Subscription Price for Rights Offering
-
Capital Square Launches Fourth Texas Active Living DST Featuring Age-Restricted Cottage Homes Near San Antonio
-
Spanish Mountain Gold Announces 2026 AGM Voting Results
-
Essential Utilities Recognizes Fire Prevention Week by Highlighting Partnership and Support for Local Departments
-
Electra Appoints General Manager to Lead Cobalt Refinery Commissioning and Operations
-
TurboGen Announces New Agreement with Leading Engineering and Manufacturing Company for Serial Development and Manufacturing of Its 20kW Systems for the Defense and Civilian Markets
-
Baker Hughes Signs Two Agreements to Develop Venezuela's Natural Gas and Energy Infrastructure
-
VisionWave Outlines Development of Autonomous Defense Ecosystem Across Tactical UAV and Counter-UAS Applications
-
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
-
Alector Enters Global License Agreement with Genentech for Brain Penetrant GCase Enzyme Replacement Therapy for Parkinson’s Disease and Other Neurodegenerative Diseases
-
DV Launches Attribution Measurement and Advances Brand Suitability for ChatGPT Ads
-
Psyence BioMed Partners with DEA-Registered Benuvia Operations to Establish U.S. Manufacture of Pharmaceutical-Grade Ibogaine
-
AIMS Surpasses 185,000 Global Active Traders, Solidifying Its Position as a Leading Regulated Prime Broker
-
Zoe Financial Research: Fee Model Tracked More Closely With Client Retention Than Age or Assets
-
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
-
Satellos Granted Composition of Matter Patent for Forazapadin
-
Dmitry Shubov Consulting Observes Cross-Border Tech and Agency Automation Trends at Cebu Summit 2026
-
Coave Therapeutics Presents Non-Human Primate Data Supporting Lead Wet AMD Gene Therapy Program at Euretina 2026
-
Viatris to Report Third-Quarter 2026 Financial Results on November 5, 2026
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Wabash Schedules Third Quarter 2026 Earnings Conference Call
